RESUMEN
The Ras association domain family (RASSF) comprises a group of tumor suppressors that are frequently epigenetically inactivated in various tumor entities and linked to apoptosis, cell cycle control and microtubule stability. In this work, we concentrated on the newly identified putative tumor suppressor RASSF10. Methylation analysis reveals RASSF10 promoter hypermethylation in lung cancer, head and neck (HN) cancer, sarcoma and pancreatic cancer. An increase in RASSF10 methylation from normal tissues, primary tumors to cancer cell lines was observed. Methylation was reversed by 5-aza-2'-deoxycytidine treatment leading to reexpression of RASSF10. We further show that overexpression of RASSF10 suppresses colony formation in cancer cell lines. In addition, RASSF10 is upregulated by cell-cell contact and regulated on promoter level as well as endogenously by forskolin, protein kinase A (PKA) and activator Protein 1 (AP-1), linking RASSF10 to the cAMP signaling pathway. Knockdown of the AP-1 member JunD interfered with contact inhibition induced RASSF10 expression. In summary, we found RASSF10 to be epigenetically inactivated by hypermethylation of its CpG island promoter in lung, HN, sarcoma and pancreatic cancer. Furthermore, our novel findings suggest that tumor suppressor RASSF10 is upregulated by PKA and JunD signaling upon contact inhibition and that RASSF10 suppresses growth of cancer cells.
RESUMEN
OBJECTIVE: To determine the types of surgical procedures currently undertaken in day clinics and to compare the number of procedures, the average in-facility cost, and the pre- and post-discharge costs for each procedure or group of procedures. DESIGN: A retrospective descriptive study of medical aid claims data. SETTING: Department of Family Medicine, University of the Witwatersrand, Johannesburg. SUBJECT: Three private sector medical aid schemes with in excess of 170,000 principal members (380,000 lives). OUTCOME MEASURES: For each surgical procedure the following were compared: (i) the total number of procedures done; (ii) the average total in-facility cost; and (iii) the cost of professional fees and medicines for 7 days before admission, during admission, and for 14 days after discharge. RESULTS: During 1997, 89,216 patients underwent surgery. Day clinics and hospitals accounted for 5,490 and 83,726 admissions respectively. Fifty-one different types of procedures were identified that met the inclusion criteria. On average the in-facility costs for 45 (88%) of the 51 compared procedures were lower in day clinics compared with hospitals. Average costs can be as much as 90% lower in day clinics. Some procedures, particularly certain dental operations, cost more in day clinics. The professional fees of attending doctors and the cost of medicines are generally higher when the procedure is undertaken in a hospital. CONCLUSION: In South Africa, as is the case in the USA, day clinics have the potential to reduce the cost of surgical procedures.
Asunto(s)
Costos de la Atención en Salud/estadística & datos numéricos , Hospitalización/economía , Centros Quirúrgicos/economía , Ahorro de Costo , Costos de los Medicamentos/estadística & datos numéricos , Honorarios Médicos/estadística & datos numéricos , Investigación sobre Servicios de Salud , Costos de Hospital/estadística & datos numéricos , Hospitalización/estadística & datos numéricos , Hospitales Universitarios , Humanos , Evaluación de Resultado en la Atención de Salud , Indicadores de Calidad de la Atención de Salud/economía , Indicadores de Calidad de la Atención de Salud/estadística & datos numéricos , Estudios Retrospectivos , Sudáfrica , Centros Quirúrgicos/estadística & datos numéricosRESUMEN
Photodynamic therapy (PDT) using the photosensitizer BPD-Verteporfin (liposomal benzoporphyrin derivative-monoacid ring A) has been shown in previous studies to be effective in the amelioration of inflammatory arthritis in both the MRL-lpr mouse and the New Zealand White (NZW) rabbit models, and could potentially offer alleviation of certain inflammation-related symptoms of rheumatoid arthritis. Time and dose dependency of BPD-MA tissue uptake was carried out in the inflamed synovium and other articular and peri-articular tissues following intravenous and intra-articular administration in the NZW rabbit model. As some articular and peri-articular tissues are difficult to extract, this study uses a rapid fluorimetric sampling of tissues following dissolution in Soluene 350. Our results showed that i.v. injected BPD-MA preferentially distributed in the inflamed synovium, and in tissues with a high degree of vascularization. Little or no association was found with avascular tissues such as cartilage and tendons. Clearance from the synovium was rapid, supporting earlier rather than late light treatment. Much higher association of BPD-MA with the synovium was achieved using intra-articular injection, and BPD-MA concentrations were maintained at relatively steady levels for several hours. These observations support the possibility that PDT could offer a safe, highly versatile clinical option for the management of inflamed joints in autoimmune disorders.
Asunto(s)
Antineoplásicos/farmacocinética , Fármacos Fotosensibilizantes/farmacocinética , Porfirinas/farmacocinética , Líquido Sinovial/metabolismo , Animales , Antineoplásicos/administración & dosificación , Artritis/inducido químicamente , Artritis/metabolismo , Inyecciones Intraarticulares , Inyecciones Intravenosas , Liposomas , Ovalbúmina , Fotoquimioterapia , Fármacos Fotosensibilizantes/administración & dosificación , Porfirinas/administración & dosificación , Conejos , Distribución Tisular , VerteporfinaRESUMEN
OBJECTIVE: To study the efficacy and mechanism of local transdermal photodynamic therapy (tPDT) in rabbits with antigen-induced arthritis (AIA). METHODS: AIA in rabbits on day 14 postinduction was treated with an intravenous injection of benzoporphyrin-derivative monoacid ring A (BPD; Verteporfin) and subsequent transdermal exposure of the knee joint to light. BPD uptake and PDT-induced apoptosis of the synovium was studied applying fluorescence confocal microscopy and immunohistochemistry. The (histo)pathology of the joints was assessed at day 28. RESULTS: Treatment with tPDT resulted in significant amelioration of synovial inflammation and an almost complete prevention of pannus formation and bone and cartilage destruction. BPD uptake was detectable in activated T cells and macrophages, and there was significant PDT-induced increase in the number of apoptotic cells in the synovium. CONCLUSION: Because photodynamic therapy is both specific and noninvasive, our findings suggest that it could be used for treating arthritic joints in humans.
Asunto(s)
Apoptosis/fisiología , Artritis Experimental/patología , Artritis Experimental/terapia , Fotoquimioterapia , Administración Tópica , Animales , Artritis Experimental/sangre , Análisis Químico de la Sangre , Femenino , Fluorescencia , Inmunohistoquímica , Microscopía Confocal , Fármacos Fotosensibilizantes/farmacocinética , Porfirinas/farmacocinética , Conejos , VerteporfinaRESUMEN
In this study we compared the plasma distribution and arterial accumulation of a photosensitizer, benzoporphyrin derivative (BPD), in two models of atherosclerosis: the spontaneous lesions of the Watanabe heritable hyperlipidemic (WHHL) rabbit and induced lesions of the balloon-injured, cholesterol-fed New Zealand white (NZW) rabbit. Selective uptake and retention of a photosensitizer by the abnormal portion of a vessel is a necessity in order for photodynamic therapy to become a successful modality for inhibition of intimal hyperplasia, selective removal of atherosclerotic tissue or imaging of diseased arteries. Liposome-based formulations were compared to freshly isolated native low density lipoprotein (LDL) and acetylated-LDL (Ac-LDL) as delivery vehicles for BPD. Plasma distribution of the photosensitizer was analyzed by KBr density gradient ultracentrifugation. Although the delivery vehicle influenced plasma distribution immediately postinjection, BPD subsequently partitioned according to the plasma concentration of the lipoproteins. Photosensitizer level in plaque and normal artery specimens was determined by ethyl acetate extraction and spectrofluorometric measurement. The measurement of BPD in normal and atherosclerotic arterial tissue demonstrated a selective accumulation in atherosclerotic tissue. Preassociation with LDL and Ac-LDL enhanced accumulation of BPD in atherosclerotic tissue when compared with normal artery (mean ratios of 2.8 and 4.1 were achieved, respectively). These results indicate that the preferential uptake of BPD by atherosclerotic plaque can be enhanced by preassociation with plasma lipoproteins, suggesting that light activation could lead to a highly selective destruction of diseased vascular tissue.
Asunto(s)
Arteriosclerosis/patología , Hiperlipidemias/patología , Fármacos Fotosensibilizantes/farmacocinética , Porfirinas/farmacocinética , Angioplastia , Animales , Arteriosclerosis/sangre , Arteriosclerosis/metabolismo , Colesterol en la Dieta/efectos adversos , Sistemas de Liberación de Medicamentos , Endotelio Vascular/metabolismo , Inhibidores Enzimáticos/metabolismo , Hiperlipidemias/sangre , Hiperlipidemias/metabolismo , Lipoproteínas LDL/metabolismo , Liposomas , Fármacos Fotosensibilizantes/administración & dosificación , Fármacos Fotosensibilizantes/sangre , Fototerapia/métodos , Porfirinas/administración & dosificación , Porfirinas/sangre , ConejosRESUMEN
Benzoporphyrin derivative (BPD) is a potent photosensitizer in biological systems. There are four structural analogues of BPD. The analogues share the same chromophor, which results in their having almost identical optical spectra, extinction coefficients, and yields of singlet oxygen. Small structural differences affect their photosensitizing potency in various biological systems, and thus make them an interesting tool to study the structure-activity relationship. The ranking of the photosensitizing potency of the analogues differed depending on the test system. The more efficient photosensitization of tumor cell lines by the highly lipophilic monoacids as compared to that by less lipophilic diacids correlated positively with the partition coefficient, and was related to the rate of diffusion into the cells. However, in the assay systems where PDT targets were located in the membrane (red blood cells hemolysis, enveloped vesicular stomatitis virus, isolated mitochondria) there was very little difference in photosensitizing potency of BPD analogues. The results indicate that the evaluation of photosensitizers is affected by the test system and thus for photosensitizers screening purposes, the choice of the test system should be made based on the intended ultimate use.
Asunto(s)
Evaluación de Medicamentos/métodos , Porfirinas/química , Animales , Bovinos , Hemólisis/efectos de los fármacos , Hemólisis/efectos de la radiación , Humanos , Ratones , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Mitocondrias Hepáticas/efectos de la radiación , Estrés Oxidativo , Oxígeno/metabolismo , Fármacos Fotosensibilizantes/química , Fármacos Fotosensibilizantes/farmacocinética , Fármacos Fotosensibilizantes/farmacología , Porfirinas/farmacocinética , Porfirinas/farmacología , Ratas , Oxígeno Singlete , Relación Estructura-Actividad , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/efectos de la radiación , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/efectos de la radiaciónRESUMEN
Benzoporphyrin derivative monoacid ring A (BPD), a hydrophobic chlorin-like porphyrin derivative, which fluoresces strongly at 690 nm, may have potential for both oncologic and nononcologic applications in photodynamic therapy (PDT). To study the influence of cellular characteristics on the uptake of BPD, the murine tumor cell line (P815), and in vitro and in vivo concanavalin A (Con A) -stimulated and unstimulated murine splenic lymphocytes were incubated with 2 micrograms/mL BPD at 37 degrees C for 0-60 min. At various times, cells were lysed and the amount of BPD taken up by cells was quantified by fluorescence measurements. The subsets of cells taking up BPD were analyzed using a panel of monoclonal antibodies and the Coulter XL fluorescence-activated cell sorter. Furthermore, Con A-stimulated and unstimulated spleen cells were incubated with 0-50 ng/mliter of BPD for 1 h prior to exposure to red light (7.2 J/cm2). Cell survival 24 h post-PDT was measured by the MTT assay. We found that the rapidly dividing tumor cell line and mitogen-stimulated murine T cells (mainly CD4+/IL-2R+) took up significantly more BPD (5-10-fold) than do unstimulated splenic lymphocytes. Increased BPD uptake correlated with greater photoinactivation when these cells were exposed to light at a wavelength of 690 nm. These findings suggest that activated cells of the immune system may be a target for photoinactivation by BPD.
Asunto(s)
Activación de Linfocitos , Linfocitos/efectos de los fármacos , Fármacos Fotosensibilizantes/farmacología , Porfirinas/farmacología , Bazo/citología , Animales , Médula Ósea/efectos de los fármacos , Células de la Médula Ósea , Citometría de Flujo , Ratones , Mitógenos/farmacología , Fotoquimioterapia , Células Tumorales CultivadasRESUMEN
Physicians and certified nurse-midwives have worked together in hospitals, private practices, clinics and birth centers throughout Florida for over 20 years. A questionnaire was sent to all maternal health-care providers to develop an understanding of the perceived attitudes, benefits, or liabilities of the professional relationships between them. An analysis is provided of the 374 physician responses.
Asunto(s)
Actitud del Personal de Salud , Relaciones Interprofesionales , Enfermeras Obstetrices , Médicos , Servicios Contratados , Medicina Familiar y Comunitaria , Femenino , Florida , Predicción , Ginecología , Humanos , Jurisprudencia , Servicios de Salud Materna , Persona de Mediana Edad , Obstetricia , Embarazo , Atención Prenatal , Derivación y ConsultaRESUMEN
In vitro experiments with benzoporphyrin derivative monoacid ring A (BPD) confirmed earlier studies that it was taken up rapidly (within 30 min) to maximum concentrations by all cells tested. It was also confirmed that rapidly dividing tumor cell lines and mitogen-activated murine T lymphocytes took up significantly more (5-10-fold) BPD than did normal splenic lymphocytes. Further experiments were undertaken to determine whether BPD could be activated by whole-body irradiation with red light in the blood of animals, shortly after intravenous (i.v.) administration, in the absence of skin photosensitivity. It was found that shaved and depilated mice injected i.v. 60 min earlier with BPD at between 0.5 and 1.0 mg/kg could tolerate 160 J/cm2 of broad-band red light (560-900 nm) delivered, at a relatively low rate, over a 90 min time interval without developing skin photosensitivity or general phototoxicity. During the treatment time, plasma levels of BPD were between 0.7 and 1.0 micrograms/mL. The light treatment resulted in between 70 and 80% photoinactivation of circulating BPD. When L1210 tumor cells were preincubated with BPD and injected i.v. into mice immediately before total-body light treatment (160 J/cm2 of 590-900 nm light delivered over 90 min), significant reductions in circulating clonogenic tumor cells were observed in blood samples taken immediately following treatment. This indicated that sufficient light was being delivered to BPD in the blood flowing in the peripheral vasculature to effect cytotoxicity to cells containing the photosensitizer without causing either vascular or skin photosensitivity.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Porfirinas/sangre , Porfirinas/efectos de la radiación , Animales , Transporte Biológico Activo , Línea Celular , Técnicas In Vitro , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos DBA , Fotoquimioterapia/métodos , Porfirinas/farmacocinética , Piel/metabolismo , Piel/efectos de la radiación , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
Biodistribution studies were carried out on 14C-labeled benzoporphyrin derivative monoacid ring A (BPD), which had been formulated as a unilamellar liposome or taken from a stock solution in dimethyl sulfoxide diluted into phosphate-buffered saline immediately before intravenous injection into DBA/2 mice. By and large the general distribution of BPD to various organs and tissues was comparable for both formulations. It was noted, however, that liposomal material appeared to enter tissues more rapidly and to be cleared more rapidly, as demonstrated by shorter half-lives for a number of tissues including skin, lung and fat, and generally lower levels in most tissues 24 h following administration. Accumulation in tumor tissue was slightly higher with liposomal BPD, and clearance rates for this tissue were equivalent (half-lives 16.1 h for liposomal BPD and 16.9 h for aqueous BPD). When the two preparations were tested in a bioassay in tumor-bearing mice, photodynamic therapy (PDT) with liposomal BPD proved to be superior to the aqueous preparation when PDT was administered 3 h following intravenous administration of BPD. Plasma distribution studies in vitro demonstrated that 91.1 +/- 0.3% of the liposomal BPD distributed to the lipoprotein fraction within the first hour of mixing, whereas only 49.1 +/- 2.6% of nonliposomal BPD was associated with lipoprotein under the same conditions. Furthermore, while lipoprotein-associated liposomal BPD distributed evenly between all three types of lipoprotein (high, low and very low density), a majority of nonliposomal BPD associated with the high-density lipoprotein fraction.
Asunto(s)
Neoplasias Experimentales/tratamiento farmacológico , Porfirinas/administración & dosificación , Animales , Lipoproteínas/metabolismo , Liposomas , Masculino , Ratones , Ratones Endogámicos DBA , Neoplasias Experimentales/metabolismo , Fotoquimioterapia , Porfirinas/farmacocinética , Fármacos Sensibilizantes a Radiaciones/administración & dosificación , Fármacos Sensibilizantes a Radiaciones/farmacocinética , Distribución TisularRESUMEN
Benzoporphyrin derivative (BPD) has been demonstrated to be a new potent photosensitizer for photodynamic therapy (PDT). Although most of the work on BPD has been focused on its potential applications for cancer treatment, BPD may have potential clinical uses in the treatment of atherosclerosis. The purpose of this study was to determine in vitro and in vivo uptake of BPD into atherosclerotic plaque. Samples of atherosclerotic human femoral and popliteal arteries were incubated with BPD-monoacid, ring A (BPD-MA) for 1 h in the following concentrations: 1, 5, 10, 20, 30 and 40 micrograms/mL. Fluorescence from all samples was determined by chemical extraction with a spectrofluorometer. The tissue concentration for human arteries was 0.37 +/- 0.03, 2.78 +/- 1.5, 3.6 +/- 1.91, 7.15 +/- 2.36, 8.06 +/- 3.09 and 14.6 +/- 4.81 micrograms/g, respectively. In addition, three miniswine were rendered atherosclerotic and given BPD 2.0 mg/kg intravenously. The concentration of BPD-MA in miniswine aorta was 93-190 ng/g and the plaque/normal ratio was 1.7-3.5. For miniswine iliac arteries, the [BPD-MA] was 60-178 ng/g and the plaque/normal ratio was 1.1-3.3. Normal miniswine carotid artery contained 54 ng/g. This study showed that BPD-MA was taken up in atherosclerotic vessels both in vitro and in vivo and may have potential for PDT of atherosclerosis.
Asunto(s)
Arteriosclerosis/metabolismo , Fármacos Fotosensibilizantes/metabolismo , Porfirinas/metabolismo , Animales , Arteriosclerosis/patología , Transporte Biológico , Femenino , Arteria Femoral/metabolismo , Humanos , Arteria Ilíaca/metabolismo , Cinética , Músculo Liso Vascular/metabolismo , Fármacos Fotosensibilizantes/farmacocinética , Arteria Poplítea/metabolismo , Porfirinas/farmacocinética , Porcinos , Porcinos EnanosRESUMEN
Biodistribution of the photosensitizer benzoporphyrin derivative monoacid ring A (BPD) was compared in DBA/2 mice bearing the syngeneic M-1 tumor and nude mice bearing the A549 human squamous cell carcinoma. These studies, using internally labeled 14C-BPD showed that in general, biodistribution between the two strains was equivalent with the exception of two tissues; lymph nodes (BPD levels were higher in nude mice) and tumor (BPD levels were lower in nude mice). Further studies were carried out in A549-tumor-bearing nude mice in which the biodistribution of BPD conjugated to a monoclonal antibody (5E8) with specificity for an antigen on A549 cells was compared to a conjugate prepared with an irrelevant monoclonal antibody (T48). These studies showed that both conjugates had biodistribution characteristics which distinguished them from free BPD in that they remained in the circulation and most tissues for significantly longer times than did free BPD. Also, with the exception of the 5E8-BPD conjugate and A549 tumor tissue, levels in all tissues were highest at the 3-h time point following injection of conjugates. In the case of A549 tumor and the 5E8-BPD conjugate the highest concentration of 14C-labeled material was observed at the 14-h time point following injection. The results reported herein show that the conjugates tested behaved differently from free BPD, indicating that the materials did not become dissociated in vivo and that the specific conjugate (5E8-BPD) demonstrated specificity for the A549 tumor in terms of the kinetics of its accumulation in tumor tissue.
Asunto(s)
Anticuerpos Monoclonales , Carcinoma de Células Escamosas/metabolismo , Neoplasias Experimentales/metabolismo , Fármacos Fotosensibilizantes/farmacocinética , Porfirinas/farmacocinética , Animales , Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos , Carcinoma de Células Escamosas/inmunología , Portadores de Fármacos , Masculino , Ratones , Ratones Endogámicos DBA , Ratones Desnudos , Distribución Tisular , Células Tumorales CultivadasRESUMEN
Benzoporphyrin derivative, monoacid ring A (BPD-MA), currently in clinical trials as a photosensitizer for photodynamic therapy for cancer, consists of two regioisomers (A1 and A2) present in equal proportions. The contribution of the regioisomers to the overall photosensitizing potency of BPD-MA was tested in vitro and in vivo. The in vitro photosensitizing potencies of BPD-MA-A1 and -A2 were tested in a standard cytotoxicity assay using M1 (rhabdomyosarcoma of DBA/2 mice) tumor cells and were found to be equivalent. The in vivo photosensitizing efficacies of the regioisomers were tested in the M1 tumor model in DBA/2 mice and were also found to be equivalent. Biodistribution of the regioisomers in mouse plasma, tumor and liver was studied in M1 tumor-bearing DBA/2 mice at 15 min and 3 hr post intravenous injection of [14C]BPD-MA-A1/A2 at 4 mg/kg body weight. Plasma and extracts from tumor and liver were analysed by HPLC and tested for radioactivity. The two regioisomers were eliminated from plasma and liver at different rates, which resulted in A1:A2 ratios of 1:0.28 in plasma and 1:0.75 in liver at 3 hr post injection. The differential elimination was not observed to any significant degree in the tumor, where even at 3 hr post injection the A1:A2 ratio was 1:1.15. Therefore, we concluded that in tumor tissue, at 3 hr post injection, the time at which laser photodynamic therapy is carried out, both regioisomers were present in about equal proportions. Further, both regioisomers were fully active as determined by an in vitro cytotoxicity assay following extraction.
Asunto(s)
Porfirinas/química , Fármacos Sensibilizantes a Radiaciones/química , Animales , Ensayos de Selección de Medicamentos Antitumorales , Isomerismo , Ratones , Ratones Endogámicos DBA , Fotoquímica , Porfirinas/farmacocinética , Porfirinas/farmacología , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
The influence of lipoprotein association on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative (BPD) has been investigated in M-1 tumor bearing mice. The association of benzoporphyrin mono acid ring A with either low or high density lipoprotein increased tumor cell killing in an in vivo/in vitro cytotoxicity assay performed 3 h post intravenous drug administration. Eight hours following photosensitizer injection only low density lipoprotein (LDL) mixtures produced significant (P less than or equal to 0.005) increases in tumor cell killing compared to BPD in unfractionated plasma. The efficacy of in vivo photosensitization in the presence of lipoproteins correlated with the in vivo/in vitro cytotoxicity. Association of BPD with low or high density lipoproteins resulted in delayed tumor regrowth and higher cure rates when light exposure (125J/cm2) was performed 3 h post drug administration. When light exposure was performed 8 h post-injection only LDL-BPD mixtures led to enhanced tumor eradication compared to BPD administered in aqueous solution or unfractionated plasma.
Asunto(s)
Lipoproteínas/fisiología , Neoplasias Experimentales/radioterapia , Trastornos por Fotosensibilidad , Fototerapia , Porfirinas/fisiología , Animales , Muerte Celular , Inyecciones Intravenosas , Lipoproteínas/sangre , Masculino , Ratones , Ratones Endogámicos DBA , Neoplasias Experimentales/inducido químicamente , Porfirinas/química , Porfirinas/toxicidad , RatasRESUMEN
We determined serum alpha 1-antitrypsin phenotypes and levels in 281 patients with classical or definite rheumatoid arthritis (RA). The prevalence of the MZ phenotype in our patients with RA was not increased, as there were only 3 MZ cases (1.1% of all cases and 1.4% of seropositive cases) compared to the 3% prevalence in controls. The FM phenotype was detected in 6 cases, a prevalence rate of 2.1%, significantly higher than in controls (prevalence less than 0.4%). Increased serum levels of alpha 1-antitrypsin were independently associated (p less than 0.01) with the presence of wrist joint erosions and the use of gold and/or penicillamine for treatment; this association may represent a serum antitrypsin response to more severe disease.
Asunto(s)
Artritis Reumatoide/sangre , alfa 1-Antitripsina/análisis , Adulto , Anciano , Anciano de 80 o más Años , Artritis Reumatoide/tratamiento farmacológico , Artritis Reumatoide/patología , Femenino , Oro/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Penicilamina/uso terapéutico , Fenotipo , Índice de Severidad de la EnfermedadRESUMEN
A comparative study, at both the macroscopic and microscopic level, of skin photosensitivity caused by four isomeric forms of benzoporphyrin derivative (BPD) has been carried out, and compared to effects of Photofrin. Animals injected intravenously with BPD analogues and exposed to light 3 h later showed extensive photosensitivity. Animals receiving the monoacid derivatives of BPD (BPD-MA and BPD-MB) showed markedly more photosensitivity than those receiving the diacid derivatives (BPD-DA and BPD-DB). Animals receiving BPD analogues which were exposed to light 24 h or more later showed only minimal reactivity. Histological examination of biopsies taken after photosensitizer injection and light exposure showed extensive changes in epidermis and dermis, including epidermal erosion, degranulation of the stratum granulosum, spongiosis, depletion in cellularity and mast cell degranulation. These changes were noted to be similar to changes caused by Photofrin.
Asunto(s)
Hematoporfirinas/farmacología , Porfirinas/farmacología , Fármacos Sensibilizantes a Radiaciones/farmacología , Piel/patología , Animales , Relación Dosis-Respuesta en la Radiación , Derivado de la Hematoporfirina , Luz , Masculino , Ratones , Ratones Endogámicos DBA , Necrosis , Piel/efectos de los fármacos , Piel/efectos de la radiaciónRESUMEN
The in vivo characteristics of four analogues of benzoporphyrin derivative (BPD) have been investigated. Biodistribution data obtained in DBA/2J mice with BPD-MA (monoacid ring A analogue) which had been tritiated or internally labelled with 14C showed that both labelled materials acted in an essentially identical manner during the period of study. Biodistribution and clearance studies showed that relative distribution in a variety of mouse tissues was similar for all BPD analogues. M1 tumour cells (rhabdomyosarcoma in DBA/2J mice) taken from tumours excised from animals treated 3 h earlier with BPD, and tested in vitro for photosensitivity provided evidence that significant levels of photosensitiser detected in tumour was both active and associated with tumour cells. The monoacid forms of BPD were found to be much more photodynamically active in this test than were the diacid analogues. The ability of the analogues to ablate tumours in mice by photodynamic therapy was also tested. Again, BPD-MA and BPD-MB proved to be measurably better than the diacid analogues. These findings are discussed in reference to structural and physical differences between the analogues.
Asunto(s)
Neoplasias Experimentales/tratamiento farmacológico , Porfirinas/farmacología , Fármacos Sensibilizantes a Radiaciones/farmacología , Animales , Radioisótopos de Carbono , Supervivencia Celular , Relación Dosis-Respuesta a Droga , Ratones , Ratones Endogámicos , Neoplasias Experimentales/metabolismo , Fotoquimioterapia , Porfirinas/farmacocinética , Distribución TisularRESUMEN
Photofrin II (dihaematoporphyrin ether/ester, DHE) was labelled with indium-111 and its biodistribution in tumour bearing mice compared with that of 111In chloride. The uptake and clearance of 111In labelled DHE differed markedly from that of indium-111 chloride in that the former was not taken up by the tissues as much as the latter. Scintillation scanning with a gamma-camera showed marked uptake of both 111In agents at the site of the tumour, but a much lower tissue background (excluding the abdominal organs) for the mice given 111In DHE. Tumour:muscle ratios of dissected tissues were 2-3 times higher in 111In DHE treated animals as compared to the uptake of 111In chloride. There was a distinct difference in the pattern of distribution of the two 111In preparations in the tissues. The major accumulation of 111In chloride was in the kidneys, whereas the highest uptake of 111In DHE was in the liver, the organ in which unlabelled porphyrins accumulate. Extraction and testing of materials from tumours of 111In DHE treated animals indicated that most of the tumour extractable 111In had remained associated with the porphyrin in vivo up to 4 days after injection.
Asunto(s)
Hematoporfirinas , Radioisótopos de Indio , Neoplasias Experimentales/diagnóstico por imagen , Animales , Éter de Dihematoporfirina , Hematoporfirinas/farmacocinética , Ratones , Ratones Endogámicos DBA , Cintigrafía , Solubilidad , Distribución TisularRESUMEN
Four structural analogs of benzoporphyrin derivative (BPD) have been studied and compared for photosensitizing activity in vitro. All analogs have an identical reduced tetrapyrrol porphyrin ring, and differ by the position of a cyclohexadiene ring (fused at either ring A or ring B of the porphyrin) and the presence of either two acid groups or one acid and one ester group at rings C and D of the porphyrin. Photosensitizer activity was tested with the M1 tumor cell line using an assay (the MTT assay) which detects mitochondrial hydrogenases as a measure of cell viability. This assay was shown to be equivalent to the standard clonogenicity or [3H]thymidine uptake assay. Comparative studies with the BPD analogs showed that the monoacid derivatives had equivalent cytotoxicity and were about five-fold more active than the diacid forms. This was the case whether the assays were performed in the presence or absence of fetal calf serum.
Asunto(s)
Supervivencia Celular/efectos de los fármacos , Porfirinas/farmacología , Fármacos Sensibilizantes a Radiaciones/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de la radiación , Replicación del ADN/efectos de los fármacos , Replicación del ADN/efectos de la radiación , Relación Dosis-Respuesta a Droga , Luz , Porfirinas/síntesis química , Fármacos Sensibilizantes a Radiaciones/síntesis químicaRESUMEN
The plasma distribution and biodistribution of benzoporphyrin derivative were examined. Two analogs of benzoporphyrin derivative were mixed with human plasma in vitro and recovered in the lipoprotein fractions upon separation by chromatography or ultracentrifugation. The majority of both analogs was recovered with high density lipoprotein. The effect of prebinding benzoporphyrin derivative to lipoproteins on the biodistribution of the drug in vivo was studied in tumor bearing DBA/2J mice. At 3, 8 and 24 h post-injection, tumor and tissue samples were excised and analyzed for benzoporphyrin derivative content. Precomplexing benzoporphyrin derivative with low density lipoprotein or high density lipoprotein led to significantly (P less than 0.05) greater tumor accumulation than in aqueous solution.